Last year, President Donald Trump’s administration worked alongside pharmaceutical companies to develop multiple COVID-19 vaccines in record time. Now, the technology from one of those vaccines may be used to create even more medical breakthroughs. According to Fortune, a nonprofit drug developer called IAVI released preliminary results for an HIV vaccine in February. The story started to gain traction on social media when health activist Dr. Ayoade Alakija tweeted about it last week. “New HIV vaccine with a 97% antibody response rate in phase I human trials,” she wrote. “This is the most effective trial HIV vaccine to date. It is based on the Moderna’s COVID vaccine.”

Source: Trump’s Legacy: Operation Warp Speed Leads to Landmark Discovery That Could Eliminate HIV